- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02996045
Clinical Decision Support (CDS) for Radiology Imaging
The Impact of Clinical Decision Support (CDS) for Radiology: A Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
With healthcare spending accounting for almost one-fifth of the U.S. economy and an even larger share of public sector budgets, there is substantial interest in innovations in healthcare delivery that can reduce the "over use" of resources that have no or low value to patients. As a result, there is a key need for rigorous evidence on scalable interventions aimed at improving the efficiency of the U.S. healthcare sector in general, and in the public sector in particular, which accounts for $1.25 trillion in annual healthcare spending.
In particular, there is widespread concern in both the medical profession and the public sector of the cost and health risks of "over-scanning". Estimates suggest that as many as 30% of imaging in the U.S. are unnecessary. Medicare direct spending on "high-cost" scans (e.g. MRs and CTs) was about $10 billion in 2012, or about 2% of total Medicare costs ; the indirect costs are likely considerably greater, since imaging often triggers additional follow up care. It is also estimated that about 2 percent of cancers in the U.S. are due to CT use.
Reflecting this concern, starting in 2018 Medicare will no longer reimburse for high-cost scans unless ordered using an "acceptable" Clinical Decision Support (CDS) system. Despite this upcoming policy change, the investigators know of no large-scale randomized trials on the impact of CDS for imaging.
The intervention in this study provides Clinical Decision Support (CDS) for targeted high-cost radiology orders, (MR, CT, NM, and PET scans), to healthcare providers treating patients in settings affiliated with the Aurora Health Care system headquartered in Wisconsin. CDS is a tool embedded in an order entry system that provides information and guidance to providers on whether their intended order is "appropriate" and whether there are more highly recommended alternatives. The randomization is at the provider level: half will receive the CDS, while the remaining half of providers in the study will serve as the control group.
The CDS will be delivered through the order-entry software, Epic, through ACR Select software, which is a leading decision support tool based on the American College of Radiology (ACR) Appropriateness Criteria.
Recommendations that appear in the CDS tool are a digitized version of guidelines created by the American College of Radiology (ACR). The guidelines score the appropriateness of a scan order for a given health indication, where indications include common symptoms and diagnosis keywords, such as "acute headache." In particular, indication-scan pairs are assigned an "appropriateness rating" from 1-9. Scores 1-3 are 'usually not appropriate,' 4-6 are 'may be appropriate,' and 7-9 are 'usually appropriate.'
To learn more about how CDS impacts ordering behavior, the investigators will investigate whether those exposed to CDS orders in ways that avoids CDS, such as placing them via clerical workers or choosing different indications. The investigators plan to analyze outcomes across different settings (Inpatient vs Outpatient and in the ED). Last, if the investigators find effects of CDS on ordering they will examine effects on utilization, including length of inpatient stays.
The primary outcome is the number of imaging orders that would produce a best-practice alert suggesting a change. The investigators conducted power calculations using a 7-month intervention window and 6 months of pre-period data to calculate the lag of the dependent variable as a control. With this control, the minimum detectible effect is a 13% reduction compared to a mean of 11 scans over that time period.
In addition, the investigators will investigate the number of scans (all high-cost, high-cost scoring 1-3, high-cost scoring 4-6, and substitution to low-cost scans. The investigators will also investigate whether treatment group orders in ways that avoids the CDS, such as placing them via clerical workers or choosing different indications. The investigators plan to analyze outcomes across different settings (Inpatient vs Outpatient and in the ED). Last, if the investigators find effects of CDS on ordering they will examine effects on utilization, including length of inpatient stays.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53204
- Aurora Health Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Medical provider actively employed at Aurora with a valid Epic log-in.
- Is a Medical Doctor (MD), Doctors of Osteopathic Medicine (DO), podiatrist (DPM), nurse practitioner (NP), physician assistant (PA), or certified nurse midwife (CNM)
- Has imaging order permissions at Aurora Health Care.
- Has at least one high- or low-cost imaging order in the year from November 1, 2015 to November 1, 2016 or is medical resident who joined Aurora since that time.
Exclusion Criteria:
- Opted out of the study prior to November 24, 2016
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
Clinical Decision Support (CDS)
|
A best practices alert (BPA) pop-up screen providing CDS will appear at physician sign-off for all scans scored 1-6, and scans scored 7-8 for which an alternative scan scored 8-9 exists. This screen will show the appropriateness score of the original scan order, and will display up to 7 alternative scans that are scored >4 and greater than or equal to the original score for the same indications and patient characteristics. It will also display a link to relevant ACR documentation relevant to the selected scan and indication. |
No Intervention: Control
Will not receive Clinical Decision Support (CDS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of scans ordered that would be subject to the CDS best practice alert
Time Frame: first 365 days after CDS is turned on for the treatment group
|
Scans where the CDS would be triggered based on the criteria listed in the intervention description
|
first 365 days after CDS is turned on for the treatment group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of high-cost scans (CT, MR, NM and PET) ordered
Time Frame: first 365 days after CDS is turned on for the treatment group
|
first 365 days after CDS is turned on for the treatment group
|
|
Number of scans ordered that would be subject to the CDS best practice alert and that ACR Select rates 1-3 ("usually not appropriate")
Time Frame: first 365 days after CDS is turned on for the treatment group
|
Scans where the CDS would be triggered and scored 1-3 based on the criteria listed in the intervention description.
|
first 365 days after CDS is turned on for the treatment group
|
Number of scans ordered that would be subject to the CDS best practice alert and that ACR Select rates 4-6 ("may be appropriate")
Time Frame: first 365 days after CDS is turned on for the treatment group
|
Scans where the CDS would be triggered and scored 4-6 based on the criteria listed in the intervention description.
|
first 365 days after CDS is turned on for the treatment group
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of low-cost scans ordered
Time Frame: first 365 days after CDS is turned on for the treatment group
|
includes X-rays, ultra sounds, mammograms, fluoroscopy and bone densitometry
|
first 365 days after CDS is turned on for the treatment group
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joseph Doyle, PhD, Massachusetts Institute of Technology
- Principal Investigator: Amy Finkelstein, PhD, Massachusetts Institute of Technology
- Principal Investigator: Sarah Reimer, MD, Aurora Health Care
- Principal Investigator: Laura Feeney, MA, Massachusetts Institute of Technology
- Principal Investigator: Sarah Abraham, Massachusetts Institute of Technology
Publications and helpful links
General Publications
- Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149. No abstract available.
- Callaghan BC, Kerber KA, Pace RJ, Skolarus LE, Burke JF. Headaches and neuroimaging: high utilization and costs despite guidelines. JAMA Intern Med. 2014 May;174(5):819-21. doi: 10.1001/jamainternmed.2014.173. No abstract available.
- Georgiou A, Prgomet M, Markewycz A, Adams E, Westbrook JI. The impact of computerized provider order entry systems on medical-imaging services: a systematic review. J Am Med Inform Assoc. 2011 May 1;18(3):335-40. doi: 10.1136/amiajnl-2010-000043. Epub 2011 Mar 8.
- Shreibati JB, Baker LC. The relationship between low back magnetic resonance imaging, surgery, and spending: impact of physician self-referral status. Health Serv Res. 2011 Oct;46(5):1362-81. doi: 10.1111/j.1475-6773.2011.01265.x. Epub 2011 Apr 21.
- Centers for Medicare & Medicaid Services, 2013. National Health Expenditures 2013 Highlights. Centers for Medicare & Medicaid Services.
- Sherman, D., 2012. Stemming the tide of overtreatment in U.S. healthcare. Reuters. Feb 16, 2012.
- U.S. Government Accountability Office, 2008. Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices [WWW Document]. URL http://www.gao.gov/products/GAO-08-452 (accessed 2.23.15).
- Consumer Reports, 2015. Surprising Dangers of CT Scans and X-rays - Consumer Reports [WWW Document]. URL http://www.consumerreports.org/cro/magazine/2015/01/the-surprising-dangers-of-ct-sans-and-x-rays/index.htm (accessed 2.25.15).
- Dehn, T.G., O'Connell, B., Hall, R.N., Moulton, T., 2000. Appropriateness of imaging examinations: current state and future approaches. Imaging Econ 13, 18-26.
- Medicare Payment Advisory Commission, 2014. Health Care Spending and the Medicare Program. MedPAC.
- Pitts, J., 2014. The Protecting Access to Medicare Act of 2014.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- JPAL-5002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CT, MR, NM, and PET Image Orders
-
Abdul Latif Jameel Poverty Action LabIcahn School of Medicine at Mount SinaiTerminatedCT and MR Image OrdersUnited States
-
Wuhan Union Hospital, ChinaRecruitingProstate Cancer | PET/MR | PET/CTChina
-
RenJi HospitalCompletedPET/CT | IMAGE | Prostate Specific Membrane AntigenChina
-
Medical University of South CarolinaSiemens Corporation, Corporate TechnologyTerminated
-
Wuhan Union Hospital, ChinaRecruiting
-
Wuhan Union Hospital, ChinaRecruitingNeuroendocrine Tumors | Osteomalacia | PET / CT | PET / MRChina
-
Institut BergoniéCompletedHypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET)France
-
Philips HealthcareCompletedCompare Image Quality Between SDCT and Conventional CT Images of Any Tissue Lesion, Determine Optimal Monochromatic Energy Level for a Coronary Artery ImageUnited States
-
Fujian Medical UniversityNot yet recruitingGastric Cancer | Peritoneal Carcinomatosis | 68Ga-FAPI PET/CT | Enhanced CT | 18F-FDG PET/CTChina
-
The First Affiliated Hospital of Xiamen UniversityCompletedTumor, Solid, FAPI, PET/CT, MetastasisChina
Clinical Trials on Clinical Decision Support (CDS)
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
HealthPartners InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Obesity | Pre HypertensionUnited States
-
Abdul Latif Jameel Poverty Action LabIcahn School of Medicine at Mount SinaiTerminatedCT and MR Image OrdersUnited States
-
University of Massachusetts, WorcesterAgency for Healthcare Research and Quality (AHRQ); Baycrest Centre for Geriatric...WithdrawnAdverse Drug Events
-
University of Colorado, DenverNot yet recruitingHeart Failure | Decision Support Systems, Clinical
-
Oregon Health and Science UniversityEnrolling by invitationAtrial FibrillationUnited States
-
University of Colorado, DenverATI Physical TherapyCompletedTotal Knee ReplacementUnited States
-
Northwestern UniversityUniversity of California, Los Angeles; National Institute on Aging (NIA); University... and other collaboratorsEnrolling by invitationPolypharmacyUnited States
-
Christopher HorvatBeckwith FoundationRecruitingBronchiolitisUnited States
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)Recruiting